Advertisement
Screener

Opus Genetics, Inc. (IRD) Shareholder Equity

Opus Genetics, Inc. (IRD) Shareholder Equity

  • 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $8.00K; Additional Paid in CapitalUSD $249.23M; Retained Earnings (Accumulated Deficit)USD $-262.22M.
  • 2026-04-02: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Retained Earnings (Accumulated Deficit)USD (m).
  • 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $208.28M; Retained Earnings (Accumulated Deficit)USD $-254.12M.
  • 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $203.93M; Retained Earnings (Accumulated Deficit)USD $-188.59M.

Opus Genetics, Inc. Shareholder Equity

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endPreferred Stock, Value, Issued
USD
Common Stock, Value, Issued
USD
Additional Paid in Capital
USD
Retained Earnings (Accumulated Deficit)
USD
Stockholders' Equity Attributable to Parent
USD
APIC, Share-based Payment Arrangement, Increase for Cost Recognition
USD
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
USD
Additional Paid in Capital, Common Stock
USD
Treasury Stock, Value
USD
AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax
USD
Accumulated Other Comprehensive Income (Loss), Net of Tax
USD
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt
USD
Treasury Stock, Value, Acquired, Cost Method
USD
Treasury Stock, Retired, Cost Method, Amount
USD
Treasury Stock, Shares, Retired
shares
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
USD
Treasury Stock, Shares
shares
2026-06-30$0.00$8.00K$249.23M$-262.22M$-12.99M3 month · $1.41M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2026-04-02(m)(m)(m)(m)(m)(m)$5.00M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2026-03-31$0.00$7.00K$208.28M$-254.12M$-45.84M3 month · $1.46M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-12-31$0.00$7.00K$203.93M$-188.59M$15.35M12 month · $3.40M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-09-30$0.00$6.00K$178.03M$-172.07M$5.97M3 month · $816.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-06-30$0.00$6.00K$172.08M$-154.61M$17.47M3 month · $896.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-03-31$0.00$5.00K$152.26M$-147.19M$5.07M3 month · $913.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-12-31$0.00$3.00K$145.72M$-139.00M$6.72M12 month · $3.36M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-09-30$0.00$3.00K$138.16M$-103.86M$34.30M3 month · $776.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-06-30$0.00$3.00K$136.97M$-96.34M$40.64M3 month · $806.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-03-31$0.00$3.00K$134.63M$-88.57M$46.06M3 month · $985.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-12-31$0.00$2.00K$131.37M$-81.47M$49.91M12 month · $3.51M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-09-30$0.00$2.00K$126.95M$-76.67M$50.28M3 month · $573.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-06-30$0.00$2.00K$119.93M$-82.23M$37.70M3 month · $1.42M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-03-31$0.00$2.00K$118.52M$-77.27M$41.25M3 month · $804.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-12-31$0.00$2.00K$117.72M$-71.48M$46.24M12 month · $1.81M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-09-30$0.00$2.00K$117.30M$-105.42M$11.88M3 month · $493.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-06-30$0.00$2.00K$115.48M$-100.89M$14.60M3 month · $445.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31$0.00$2.00K$113.23M$-95.96M$17.27M3 month · $445.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31$0.00$2.00K$111.59M$-89.37M$22.22M12 month · $1.91M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-09-30$0.00$2.00K$103.62M$-83.06M$20.57M3 month · $478.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)3 month · $50.00K(m)
2021-06-30$0.00$2.00K$101.38M$-78.83M$22.55M3 month · $463.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)3 month · $1.27M(m)
2021-03-31$0.00$1.00K$81.50M$-71.69M$9.82M3 month · $494.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31$0.00$1.00K$19.21M$-32.67M$-13.47M12 month · $1.51M12 month · $971.00K(m)(m)(m)(m)12 month · $64.00K(m)(m)(m)12 month · $1.08M(m)
2020-09-30(m)$448.00(m)$-167.82M$-9.41M3 month · $616.00K
9 month · $202.21K
(m)$173.54M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30(m)$402.00(m)$-166.42M$-8.78M3 month · $316.00K
6 month · $145.37K
(m)$173.42M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31(m)$402.00(m)$-163.91M$-8.46M3 month · $61.00K(m)$173.35M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31$0.00$0.00$495.00K$-8.05M$-7.56M12 month · $308.00K(m)$173.28M(m)(m)$2.08K(m)(m)(m)(m)(m)(m)
2019-09-30(m)$402.00(m)$-161.45M$11.76M3 month · $90.69K
9 month · $379.35K
(m)$173.20M(m)(m)$7.85K(m)(m)(m)(m)(m)(m)
2019-06-30(m)$402.00(m)$-159.49M$13.62M3 month · $127.65K
6 month · $288.65K
(m)$173.11M(m)(m)$7.18K(m)(m)(m)(m)(m)(m)
2019-03-31(m)$402.00(m)$-157.03M$15.94M3 month · $161.00K(m)$172.98M(m)(m)$-12.60K(m)(m)(m)(m)(m)(m)
2018-12-31(m)$312.00(m)$-154.69M$-1.70M12 month · $1.23M(m)$165.27M(m)(m)$-17.84K(m)(m)(m)(m)(m)(m)
2018-09-30(m)$3.17K(m)$-151.57M$6.41M3 month · $281.48K
9 month · $845.21K
(m)$158.01M(m)(m)$-29.49K(m)(m)(m)(m)(m)(m)
2018-06-30(m)$3.17K(m)$-146.23M$11.42M3 month · $267.15K
6 month · $563.73K
(m)$157.72M(m)(m)$-64.95K(m)(m)(m)(m)(m)(m)
2018-03-31(m)$3.17K(m)$-142.39M$14.97M3 month · $296.58K(m)$157.45M(m)(m)$-89.38K(m)(m)(m)(m)(m)(m)
2017-12-31(m)$3.17K(m)$-140.32M$16.77M12 month · $1.04M(m)$157.14M(m)(m)$-56.89K(m)(m)(m)(m)12 month · $1.47M(m)
2017-09-30(m)$2.85K(m)$-136.73M$15.12M(m)(m)$151.86M(m)(m)$-13.96K(m)(m)(m)(m)(m)(m)
2017-06-30(m)$2.85K(m)$-135.69M$15.90M(m)(m)$151.61M(m)(m)$-25.70K(m)(m)(m)(m)(m)(m)
2017-03-31(m)$24.50K(m)$-136.64M$1.13M(m)(m)$137.78M(m)(m)$-6.33K(m)(m)(m)(m)(m)(m)
2016-12-31(m)$2.37K(m)$-115.02M$17.06M12 month · $1.41M(m)$132.09M(m)(m)$-6.12K(m)(m)(m)(m)12 month · $837.75K(m)
2016-09-30(m)$23.74K(m)$-114.50M$17.24M(m)(m)$131.72M(m)(m)$-4.66K(m)(m)(m)(m)(m)(m)
2016-06-30(m)$21.32K(m)$-111.63M$15.81M(m)(m)$127.42M(m)(m)$2.33K(m)(m)(m)(m)(m)(m)
2016-03-31(m)$21.32K(m)$-109.87M$17.21M(m)(m)$127.06M(m)(m)$-1.41K(m)(m)(m)(m)(m)(m)
2015-12-31(m)$19.74K(m)$-105.72M$18.78M12 month · $1.04M(m)$124.49M(m)(m)$-18.04K(m)(m)(m)(m)12 month · $566.07K0.00
2015-12-03(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)$128.41K11.32K(m)(m)
2015-09-30(m)$18.09K(m)$-102.86M$17.71M(m)(m)$120.67M$128.41K(m)$6.77K(m)(m)(m)(m)(m)113.22K
2015-06-30(m)$18.07K(m)$-98.84M$21.43M(m)(m)$120.37M$128.41K(m)$5.75K(m)(m)(m)(m)(m)113.22K
2015-03-31(m)$17.93K(m)$-95.60M$23.38M(m)(m)$119.09M$128.41K(m)$1.08K(m)(m)(m)(m)(m)113.22K
2014-12-31(m)$17.84K(m)$-91.33M$26.58M12 month · $608.79K(m)$118.06M$128.41K(m)$-33.65K(m)(m)(m)(m)12 month · $1.16M113.22K
2014-09-30(m)$17.84K(m)$-89.12M$28.60M(m)(m)$117.87M$128.41K(m)$-42.04K(m)(m)(m)(m)(m)113.22K
2014-06-30(m)$17.83K(m)$-87.22M$30.31M(m)(m)$117.64M$128.41K(m)(m)(m)(m)(m)(m)(m)113.22K
2014-03-31$0.00$17.66K(m)(m)$28.03M(m)(m)$115.45M$28.41K(m)(m)(m)(m)(m)(m)(m)14.21K
2013-12-31$0.00$14.67K(m)$-72.81M$12.63M12 month · $565.43K(m)$85.45M$28.41K(m)(m)(m)(m)(m)(m)12 month · $952.49K14.21K
2013-09-30$0.00$13.45K(m)(m)$9.85M(m)(m)$79.96M$28.41K(m)(m)(m)(m)(m)(m)(m)14.21K
2013-06-30$0.00$11.98K(m)(m)$5.50M(m)(m)$73.47M$28.41K(m)(m)(m)(m)(m)(m)(m)14.21K
2013-03-31$0.00$11.94K(m)(m)$8.38M(m)(m)$73.23M$28.41K(m)(m)(m)(m)(m)(m)(m)14.21K
2012-12-31$0.00$11.94K(m)(m)$9.53M12 month · $230.99K(m)$72.86M$28.41K(m)(m)(m)(m)(m)(m)(m)14.21K
2012-09-30(m)$9.54K(m)(m)$4.74M(m)(m)$68.01M$28.41K(m)(m)(m)(m)(m)(m)(m)14.21K
2012-06-30$0.00$9.54K(m)(m)$7.67M(m)(m)$67.95M$28.41K(m)(m)(m)(m)(m)(m)(m)14.21K
2012-03-31$0.00$9.54K(m)(m)$8.66M(m)(m)$67.90M$28.41K(m)(m)(m)(m)(m)(m)(m)14.21K
2011-12-31$0.00$9.54K(m)(m)$10.71M12 month · $638.61K(m)$67.81M$28.41K$0.00(m)(m)(m)(m)(m)(m)14.21K
2011-09-30$0.00$9.53K(m)(m)$10.17M(m)(m)$67.67M$28.41K$0.00(m)(m)(m)(m)(m)(m)14.21K
2011-06-30$0.00$9.53K(m)(m)$11.48M(m)(m)$67.50M$28.41K$0.00(m)(m)(m)(m)(m)(m)14.21K
2010-12-31$0.00$8.42K(m)(m)$10.40M12 month · $584.66K(m)$56.16M$28.41K$-2.34K(m)(m)(m)(m)(m)(m)14.21K
2009-12-31(m)(m)(m)(m)$4.90M12 month · $497.53K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2008-12-31(m)(m)(m)(m)$-2.60M12 month · $484.68K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2007-12-31(m)(m)(m)(m)$958.19K12 month · $1.12M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2006-12-31(m)(m)(m)(m)$3.21M12 month · $1.03M(m)(m)(m)(m)(m)(m)12 month · $28.41K(m)(m)(m)(m)
2006-04-12(m)(m)(m)(m)(m)(m)(m)(m)$28.41K(m)(m)(m)(m)(m)(m)(m)(m)
2005-12-31(m)(m)(m)(m)$4.83M12 month · $436.75K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2004-12-31(m)(m)(m)(m)$-564.17K12 month · $230.77K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2003-12-31(m)(m)(m)(m)$2.48M12 month · $538.07K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2002-12-31(m)(m)(m)(m)$2.71M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2001-12-31(m)(m)(m)(m)$3.89M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63